Is biogen-poland.pl Safe? Security Analysis for Biogen Poland Sp. z o.o.
https://biogen-poland.plCheck if biogen-poland.pl is a scam or legitimate. Free security scan and reviews.
Above Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for biogen-poland.pl
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Biogen Poland Sp. z o.o. operates as a local subsidiary of the global biotechnology leader Biogen, focusing on innovative therapies in neurology, neuropsychiatry, immunology, and rare diseases. The website targets Polish users with comprehensive information about the company, its therapeutic areas, career opportunities, and corporate responsibility. The digital infrastructure is built on Adobe Experience Manager, leveraging modern web technologies including jQuery, Cookiebot for consent management, and Google Analytics for user insights. The site is well-structured, mobile-optimized, and compliant with GDPR regulations, featuring clear cookie and privacy policies. Security posture is strong with HTTPS enforced and secure cookie practices, though some security headers could be improved. WHOIS data is unavailable due to registry restrictions, but the site’s professional presentation and linkage to Biogen’s global domains support its legitimacy.
Detected Technologies
7 urgent findings need attention
1 critical · 6 high
Keep biogen-poland.pl under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
1 finding
95/100
GDPR Compliance
1 finding
88/100
NIS2 Compliance
9 findings
2/100
Email Security
5 findings
60/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Biogen Poland is positioned as a key regional player within the global Biogen group, focusing on high-need therapeutic areas. The business model centers on research-driven pharmaceutical development and patient-centric innovation. The website reflects a mature digital presence with clear branding and compliance adherence, supporting trust and engagement with healthcare professionals and patients. The company maintains active social media channels and provides career information, indicating growth and talent acquisition focus. Absence of direct contact emails or phone numbers on the homepage suggests controlled communication channels, likely via contact forms. The site links extensively to other Biogen regional domains, indicating a broad partnership and subsidiary network.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a solid security foundation with HTTPS, secure cookies, and a comprehensive cookie consent mechanism. However, explicit security policies, incident response contacts, and vulnerability disclosure mechanisms are not present, representing areas for improvement. No critical vulnerabilities or exposed sensitive data were detected. The use of third-party scripts like Google Analytics and Cookiebot is managed with user consent, aligning with privacy best practices. The lack of security headers such as Content-Security-Policy and X-Frame-Options could be addressed to enhance protection against common web attacks. Overall, the security posture is good but could benefit from formalized policies and additional technical controls.
Strategic Recommendations
Priority Actions for Security Improvement
Implement comprehensive security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Biogen Poland Sp. z o.o.
Biogen jest wiodącą globalną firmą biotechnologiczną, która jako pionier w dziedzinie nauki opracowuje innowacyjne metody leczenia złożonych i wyniszczających chorób. Biogen rozwija szereg potencjalnych terapii w obszarze neurologii, neuropsychiatrii, immunologii i chorób rzadkich oraz nieustannie dąży do realizacji swojego celu, jakim jest służenie ludzkości poprzez naukę, przy jednoczesnym wspieraniu zdrowszego, bardziej zrównoważonego i sprawiedliwego świata.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- Cookie consent mechanism implemented
- Use of httpOnly cookies for security
- Load balancing cookies for performance
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with no blocking or WAF challenges.
Get this report delivered to your inbox
Receive a summary of the biogen-poland.pl security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: energy, transport, health, digital
Need this report as a PDF?
Download the complete biogen-poland.pl security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
No email authentication configured
CRITICALDomain is vulnerable to email spoofing
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 88 days
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
DNS Records
DNSSEC Status
DNS Performance
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does biogen-poland.pl compare?
See how biogen-poland.pl stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the biogen-poland.pl report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the biogen-poland.pl report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about biogen-poland.pl
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published